In vitro, in vivo, and clinical studies of tedizolid to assess the potential for peripheral or central monoamine oxidase interactions.
about
Tedizolid phosphate (sivextro): a second-generation oxazolidinone to treat acute bacterial skin and skin structure infectionsThe Prodrug Approach: A Successful Tool for Improving Drug SolubilityNew developments in the management of severe skin and deep skin structure infections - focus on tedizolidTedizolid Phosphate: a Next-Generation Oxazolidinone.Safety profiles of old and new antimicrobials for the treatment of MRSA infections.Pharmacokinetic drug evaluation of tedizolid for the treatment of skin infections.Tedizolid phosphate.Serotonin syndrome associated with metaxalone overdose.Profile of tedizolid phosphate and its potential in the treatment of acute bacterial skin and skin structure infectionsPossible ameliorative effects of antioxidants on propionic acid / clindamycin - induced neurotoxicity in Syrian hamsters.Early experience with tedizolid: clinical efficacy, pharmacodynamics, and resistance.Tedizolid: a novel oxazolidinone with potent activity against multidrug-resistant gram-positive pathogens.The times they are a-changin': new antibacterials for skin and skin structure infections.Tedizolid: The First Once-Daily Oxazolidinone Class Antibiotic.Drug-drug interactions and safety of linezolid, tedizolid, and other oxazolidinones.Susceptibility testing and reporting of new antibiotics with a focus on tedizolid: an international working group report.New Gram-Positive Agents: the Next Generation of Oxazolidinones and Lipoglycopeptides.Oxazolidinone antimicrobials: a patent review (2012-2015).Therapeutic challenges posed by critical drug-drug interactions in cystic fibrosis.Diagnosis and management of skin and soft tissue infections in the intensive care unit: a review.Critical role of tedizolid in the treatment of acute bacterial skin and skin structure infectionsNeuropsychiatric Effects of Antimicrobial Agents.Successful Treatment of Prosthetic Joint Infection due to Vancomycin-resistant Enterococci with Tedizolid.Comparative efficacies of tedizolid phosphate, vancomycin, and daptomycin in a rabbit model of methicillin-resistant Staphylococcus aureus endocarditis.Linezolid-Associated Hypoglycemia.Clinical Pharmacokinetics and Pharmacodynamics of Oxazolidinones.Pharmacokinetic/pharmacodynamic parameters for treatment optimization of infection due to antibiotic resistant bacteria: a summary for practical purposes in children and adults.Safety, tolerability and pharmacokinetics of 21 day multiple oral administration of a new oxazolidinone antibiotic, LCB01-0371, in healthy male subjects.Combination of Tedizolid and Daptomycin against Methicillin-Resistant Staphylococcus aureus in an In Vitro Model of Simulated Endocardial Vegetations.Pharmacokinetics of Tedizolid and Pseudoephedrine Administered Alone or in Combination in Healthy Volunteers.
P2860
Q24561509-5D500895-3C5C-4EBA-92E6-6F35B50D443DQ26771271-77C8EBD0-CA41-45F1-9D7A-572704B9D9D5Q28083116-A141C66A-3FB9-40F3-BB19-13FA031F2BABQ33420646-63623A7C-4632-4B37-BEC6-BC5C92BCB469Q33429168-A676A513-851E-44DD-992C-8612D2746CC5Q33438834-DA57F962-D0F0-4B84-BE38-07D75C2EBFA8Q34612944-FC6D24C5-92E6-4CCA-A9D9-F40A23D50C7BQ34613294-A4B74BC2-FAD3-4174-A0A0-75D18D6B7566Q35542330-51B433B5-2BC9-482D-845F-D0E1994C85D1Q37309388-07A8C1BE-4F24-4FA9-8AD4-F17F2DF0C367Q38255366-E5A99EA0-7DF9-41D4-BFD5-215D617FC9AEQ38352171-6B204ECA-D5D3-41DA-BF50-0FC78095382BQ38438503-97A1714F-9816-4D21-8F61-3AFD90F3860CQ38536296-858E5109-053E-40E0-997C-052C3A96C82FQ38604890-F318D16E-66BD-40B1-9B7C-51E51F3548EAQ38641810-BBFD8B33-6243-4C2C-81F9-84A576D750C1Q38768071-BFFF41C1-2891-432A-8D09-C92C64B9EB91Q38783047-51B8017F-65DD-4B6D-A200-770D8ADB0A01Q38962747-FB40A887-63C3-4375-B09E-45FF3B0A6402Q38971508-94D9E2B5-7469-44E6-9BB3-45291BAEC2C6Q39067666-419207D4-029F-4C72-8CED-176CF0D022EAQ39135986-774A7710-900E-4B44-8162-C2ED8BFC2421Q40243103-9C28EE1A-F75D-4ADB-88CD-31182AA319C3Q40675142-112AB4A1-943E-4F4D-92FB-C8ECD56C794BQ45929651-AB0F9FAE-2A0E-47D3-B6DA-C0374DD59B10Q47611899-DBCA8F92-0919-438F-BA5F-BD7714FBE74DQ48197188-5C5E28F2-791A-46FB-B2E4-94664A1FFA52Q50082653-95C43BA9-DE40-4555-BC67-6E9235DC913CQ52659763-2AC0C86E-1753-4A4F-8E1A-8C77AAA27E02Q55511795-91A1148D-B958-4C21-84D6-ACF8346D7CFE
P2860
In vitro, in vivo, and clinical studies of tedizolid to assess the potential for peripheral or central monoamine oxidase interactions.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
In vitro, in vivo, and clinica ...... onoamine oxidase interactions.
@en
type
label
In vitro, in vivo, and clinica ...... onoamine oxidase interactions.
@en
prefLabel
In vitro, in vivo, and clinica ...... onoamine oxidase interactions.
@en
P2093
P2860
P356
P1476
In vitro, in vivo, and clinica ...... onoamine oxidase interactions.
@en
P2093
K Bartizal
P Prokocimer
S Flanagan
S L Minassian
P2860
P304
P356
10.1128/AAC.00431-13
P407
P577
2013-04-22T00:00:00Z